David Margel, Ph.D.
Affiliations: | 2013 | Health Policy, Management and Evaluation | University of Toronto, Toronto, ON, Canada |
Area:
Oncology, Gender Studies, PathologyGoogle:
"David Margel"Parents
Sign in to add mentor| David R. Urbach | grad student | 2013 | University of Toronto | |
| (Metformin and prostate cancer among diabetic men.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nelson AJ, Lopes RD, Hong H, et al. (2023) Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review. Jacc. Cardiooncology. 5: 613-624 |
| Golan S, Frumer M, Zohar Y, et al. (2022) Neoadjuvant Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial. European Urology Oncology |
| Keizman D, Frenkel M, Peer A, et al. (2021) Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study. Nutrients. 13 |
| Lifshitz K, Ber Y, Margel D. (2021) Role of Metabolic Syndrome in Prostate Cancer Development. European Urology Focus |
| Segal N, Ber Y, Benjaminov O, et al. (2020) Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening. Annals of Oncology. 31: 1545-1552 |
| Margel D, Ber Y, Peer A, et al. (2020) Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist. Prostate Cancer and Prostatic Diseases |
| Halstuch D, Ber Y, Kedar D, et al. (2020) Short-Term Outcomes of Active Surveillance for Low-Risk Prostate Cancer Among Men with Germline DNA Repair Gene Mutations. The Journal of Urology. 101097JU000000000000 |
| Ber Y, Segal N, Tamir S, et al. (2020) A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI-US fusion biopsy for prostate-cancer detection. Prostate Cancer and Prostatic Diseases |
| Margel D, Peer A, Ber Y, et al. (2019) Cardiovascular morbidity in a randomized trial comparing GnRH-agonist and GnRH-antagonist among patients with advanced prostate-cancer and pre-existing cardiovascular disease. The Journal of Urology. 101097JU000000000000 |
| Halstuch D, Ber Y, Margel D. (2019) Screening, Active Surveillance, and Treatment of Localized Prostate Cancer Among Carriers of Germline BRCA Mutations. European Urology Focus |